Skip to main content
Institute for Independent Impact Assessment of Biotechnology
Main menu
News
Topics
Synthetic biology
Conflict of interests
Projects
Coronavirus SARS-CoV-2
Scienceblog
Limits to biotech
Research project RAGES
Genetip
EU approvals
Legal cases
Patents and animal rights
Uncontrolled spread of transgenes
Independent risk assessment
Publications
About us
Annual reports
Imprint
Contact
Set Limits to Biotech!
Assess the consequences!
Participate
Videos
Support
Contribute online
Sustaining membership
Info Material
Participate
English
Deutsch
Veröffentlichungsjahr
(-)
Remove 2018 filter
2018
Publications
Publication year:
2018
Testbiotech comment on “Scientific Opinion on application (EFSA-GMO-DE-2011-95) for the placing on the market of genetically modified maize 5307" from Syngenta
2018
Testbiotech_Comment_Maize 5307.pdf
Differences: Genome editing and mutagenesis
2018
Table_comparison CRISPR & mutagenesis_2.pdf
Unterschiede: Genome Editing und Mutagenese
Testbiotech Basis-Text
2018
Tabelle Vergleich CRISPR & Mutagenese_2.pdf
Legal analysis: The genome editing technique is covered by Directive 2001/18
Comment on Advocate Bobeks Opinion in case C-528/16
Professor Ludwig Kraemer
2018
Legal dossier_GMO - genome editing_2018.pdf
Testbiotech on risk assessment of Golden Rice by FSANZ (February 2018)
2018
Testbiotech on risk assessment of Golden Rice by FSANZ_Preliminary Version.pdf
Testbiotech comment on EFSA GMO Panel Assessment of genetically modified oilseed rape MS8, RF3 and MS8×RF3 for renewal of authorisation under regulation (EC) No 1829/2003 (EFSA-GMO-RX-004)
2018
TBT comment MS8 x RF3_2018.pdf
Testbiotech comment on EFSA´s opinion on the assessment of genetically modified maize 1507 x 59122 x MON810 x NK603 and subcombinations, for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA-GMO-NL-2011-92) by company DowDuPont
2018
Testbiotech_Comment_Maize 1507_59122_MON810_NK603.pdf
Pages
« first
‹ previous
1
2
3
newsletter
Support our work
Database
Science Blog